The White House has plunged much of the government’s health-care apparatus into disarray.
The National Science Foundation's funding freeze, and wider confusion about the status and future of science funding, is already hampering research.
Officials at the U.S. Centers for Disease Control and Prevention and other federal health agencies are scrubbing or taking down webpages, forms and programs that reflect "gender ideology extremism" on Friday to conform with an executive order that recognizes only two sexes: male and female.
The National Institutes of Health funds research, but some scientists fear that funding may be pulled or paused by the Trump administration.
Trump has frozen all travel and communications at the Department of Health and Human Services, including the CDC and the National Institutes of Health
Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the Senate Committee on Health, Education, Labor and Pensions.
One of the most admired research agencies in the world, the US National Institutes of Health, now has a huge target on its back. How did an organisation supported by both Democrat and Republican politicians become so vulnerable?
Robert F. Kennedy, President Donald Trump's nominee for health and human services secretary, survives two heated confirmation hearings but still faces crucial Senate votes.
An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded. Scientists worry about disruptions to critical research.
It was a massive change that hit many federal websites on Friday as LGBTQ+ material was purged, as well as public health data.
If he is confirmed as Health and Human Services secretary, Robert F. Kennedy Jr. would take over a sprawling bureaucracy with an annual budget that tops $1.7 trillion, with more than 80,000 employees and 13 divisions.
A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood pressure control continues to significantly reduce the risk of mild cognitive impairment or dementia long after stopping this treatment in adults with hypertension and high cardiovascular risk.